Showing results (341-350 of 395) with videos related to

Sort By:
Pageof 40
Clinical Lymphoma, Myeloma & Leukemia|August 27, 2019
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic LeukemiaThomas J Kipps, Graeme Fraser, Steven E Coutre, et al.
Blood|January 13, 2026
The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic LeukemiaOthman Al-Sawaf, Benjamin Nick Locher, Friederike Christen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2016
Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow TransplantationMohamed A Kharfan-Dabaja, Ambuj Kumar, Mehdi Hamadani, et al.
The New England Journal of Medicine|May 30, 2014
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinibJennifer A Woyach, Richard R Furman, Ta-Ming Liu, et al.
Hemasphere|July 10, 2023
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER TrialGerhard Held, Lorenz Thurner, Viola Poeschel, et al.
Blood|March 22, 2014
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trialStephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, et al.
Leukemia|April 27, 2024
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma networkLuca Fischer, Linmiao Jiang, Jan Dürig, et al.
Blood Advances|December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Age Kos, Evi Regitz, et al.
The New England Journal of Medicine|January 24, 2014
Idelalisib and rituximab in relapsed chronic lymphocytic leukemiaRichard R Furman, Jeff P Sharman, Steven E Coutre, et al.
The New England Journal of Medicine|June 21, 2013
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphomaMichael L Wang, Simon Rule, Peter Martin, et al.
Pageof 40